미국의 인공 각막 임플란트 시장 규모, 점유율, 동향 분석 보고서 : 이식 종류별, 적응증별, 임플란트 종류별, 최종 용도별, 부문별 예측(2025-2033년)

U.S. Artificial Corneal Implants Market Summary

The U.S. artificial corneal implants market size was estimated at USD 39.1 million in 2024 and is projected to reach USD 69.8 million by 2033, growing at a CAGR of 6.7% from 2025 to 2033. The market is driven by an increasing prevalence of corneal disorders such as corneal blindness and a shortage of cornea donors, which is leading patients and surgeons to seek synthetic alternatives.

The market is driven by increasing incidences of Keratoconus, Stevens-Johnson syndrome, and corneal scarring, which remain leading causes of vision impairment. The increasing prevalence of these disorders among the aging U.S. population has further increased the need for effective treatment solutions. According to the National Council on Aging, in 2022, the U.S. had 57.8 million adults aged 65 and older, comprising 31.9 million women and 25.9 million men.

To address this demand, key market participants invest heavily in R&D, securing regulatory approvals, and collaborating with clinical and academic institutions to introduce innovative implant solutions. Strategic initiatives, including partnerships, geographic expansion, and integration of advanced biomaterials, enhance their competitive positioning and expand market reach. In January 2025, Pantheon Vision collaborated with Eyedeal Medical to advance production and commercialization of its bioengineered corneal implant. Pantheon completed three FDA review meetings for Premarket approval (PMA) guidance. The partnership aimed to address limitations of donor corneas by offering bioengineered corneal implants and restoring vision in patients with corneal blindness.

U.S. Artificial Corneal Implants Market Report Segmentation

This report forecasts revenue growth at country level as well as provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. artificial corneal implants market report on the basis of transplant type, indication, implant type, and end-use:

• Transplant Type Outlook (Revenue, USD Million, 2021 - 2033)
• Hard Keratprosthesis
  • Boston Kpro
  • Osteo-Odonto-Keratoprosthesis
• Soft Keratoprosthesis
• Indication Outlook (Revenue, USD Million, 2021 - 2033)
• Stevens-Johnson Syndrome (SJS)
• Ocular Cicatricial Pemphigoid (OCP)
• Ocular burns
• Keratoconus
• Corneal Stromal Dystrophies
• Others
• Implant Type Outlook (Revenue, USD Million, 2021 - 2033)
• Synthetic
• Biosynthetic
• End-use Outlook (Revenue, USD Million, 2021 - 2033)
• Hospitals
• Ophthalmic Centers
• Ambulatory Surgical Centers

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Market Definitions
• 1.3. Research Methodology
  • 1.3.1. Information Procurement
  • 1.3.2. Information or Data Analysis
  • 1.3.3. Market Formulation & Data Visualization
• 1.4. Information Procurement
  • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. U.S. Artificial Corneal Implants Market Variables, Trends & Scope

• 3.1. Market Introduction/Lineage Outlook
• 3.2. Market Size and Growth Prospects (USD Million)
• 3.3. Market Dynamics
  • 3.3.1. Market Drivers Analysis
  • 3.3.2. Market Restraints Analysis
• 3.4. U.S. Artificial Corneal Implants Market Analysis Tools
  • 3.4.1. Porter's Analysis
    • 3.4.1.1. Political landscape
    • 3.4.1.2. Economic and Social landscape
    • 3.4.1.3. Technological landscape
    • 3.4.1.4. Environmental landscape
    • 3.4.1.5. Legal landscape
  • 3.4.2. PESTEL Analysis
    • 3.4.2.1. Bargaining power of the suppliers
    • 3.4.2.2. Bargaining power of the buyers
    • 3.4.2.3. Threats of substitution
    • 3.4.2.4. Threats from new entrants
    • 3.4.2.5. Competitive rivalry

Chapter 4. U.S. Artificial Corneal Implants Market: Transplant Type Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. U.S. Artificial Corneal Implants Market: Transplant Type Analysis, 2024 & 2033 (USD Million)
• 4.3. Hard Keratoprosthesis
  • 4.3.1. Hard Keratoprosthesis Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.3.2. Boston Kpro
    • 4.3.2.1. Boston Kpro Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.3.3. Osteo-Odonto-Keratoprosthesis
    • 4.3.3.1. Osteo-Odonto-Keratoprosthesis Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.4. Soft Keratoprosthesis
  • 4.4.1. Soft Keratoprosthesis Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. U.S. Artificial Corneal Implants Market: Indication Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. U.S. Artificial Corneal Implants Market: Indication Analysis, 2024 & 2033 (USD Million)
• 5.3. Stevens-Johnson syndrome (SJS)
  • 5.3.1. Stevens-Johnson syndrome (SJS) Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.4. Ocular Cicatricial Pemphigoid (OCP)
  • 5.4.1. Ocular Cicatricial Pemphigoid (OCP) Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.5. Ocular Burns
  • 5.5.1. Ocular Burns Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.6. Keratoconus
  • 5.6.1. Keratoconus Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.7. Corneal Stromal Dystrophies
  • 5.7.1. Corneal Stromal Dystrophies Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.8. Others
  • 5.8.1. Others Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. U.S. Artificial Corneal Implants Market: Implant Type Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. U.S. Artificial Corneal Implants Market: Implant Type Analysis, 2024 & 2033 (USD Million)
• 6.3. Synthetic
  • 6.3.1. Synthetic Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.4. Biosynthetic
  • 6.4.1. Biosynthetic Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Recent Developments & Impact Analysis, By Key Market Participants
• 7.2. Company/Competition Categorization
• 7.3. Company Heat Map Analysis
• 7.4. Company Profiles
  • 7.4.1. CorneaGen
    • 7.4.1.1. Company Overview
    • 7.4.1.2. Financial Performance
    • 7.4.1.3. Product Benchmarking
    • 7.4.1.4. Strategic Initiatives
  • 7.4.2. AJL Ophthalmic S.A.
    • 7.4.2.1. Company Overview
    • 7.4.2.2. Financial Performance
    • 7.4.2.3. Product Benchmarking
    • 7.4.2.4. Strategic Initiatives
  • 7.4.3. Alcon inc.
    • 7.4.3.1. Company Overview
    • 7.4.3.2. Financial Performance
    • 7.4.3.3. Product Benchmarking
    • 7.4.3.4. Strategic Initiatives
  • 7.4.4. KeraMed, Inc.
    • 7.4.4.1. Company Overview
    • 7.4.4.2. Financial Performance
    • 7.4.4.3. Product Benchmarking
    • 7.4.4.4. Strategic Initiatives
  • 7.4.5. FCI
    • 7.4.5.1. Company Overview
    • 7.4.5.2. Financial Performance
    • 7.4.5.3. Product Benchmarking
    • 7.4.5.4. Strategic Initiatives